Thursday, December 13, 2018

Cornea

New FDA approval: OXERVATE.

Oxervate was approved on August 22nd for the treatment of neurotrophic keratitis. Refresh me on neurotrophic keratitis. Patients with neurotrophic keratitis have decreased corneal sensitivity, epithelial breakdown,...

And then there were three.

We've got a new dry eye med to prescribe. The FDA just approved Cequa ("see-qwa"), a prescription eye drop indicated to increase tear production in patients...

What your patient might ask you…

Are there any new drops for dry eye? Always. Allergan announces the launch of Refresh Repair lubricant eye drops. How is this different than all the others? This over-the-counter drop is focused...

Weekly social media roundup.

Careful how hard you blow your nose. This patient gave herself an orbital fracture after blowing her nose. Fox news anchor has EBMD. The story details her painful experience with...

What was the most talked about study last week?

The DREAM study. What's the DREAM study? The Dry Eye Assessment and Management trial. It's a year long study to evaluate the effects of long-term omega-3 supplementation...

Maybe don’t recommend the Raindrop Near Vision Inlay anymore.

The company that makes the inlay, ReVision Optics, has closed their doors.

What your patient might ask you…

Am I more likely to get an infection because I wear colored contacts? According to a new study, yes. The study examined clear and colored contacts (Acuvue...

Superglue that people willingly put in the eye.

A study published last week showed that a new hydrogel sealant can help soldiers with traumatic eye injuries in the field. The sealant is a "temperature-responsive synthetic...

Weekly social media roundup.

Go to a water park, get a parasite. A man is suing a water park after getting splashed in the eye with water and then developing microsporidia keratitis. YouTube:...

What your patient might ask you…

What other prescription options do I have to treat my dry eye? You may start hearing about CyclASol, another dry eye medication currently in clinical trials....

Want this news in your inbox?

Subscribe to the weekly email (it’s free!)